Serelaxin Treatment Reverses Vascular Dysfunction and Left Ventricular Hypertrophy in a Mouse Model of Type 1 Diabetes

Scientific Reports - United Kingdom
doi 10.1038/srep39604
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment of Diastolic Dysfunction in Hypertensive Patients Without Left Ventricular Hypertrophy

Journal of Human Hypertension
Internal Medicine
1998English

159 Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy

Heart
Cardiovascular MedicineCardiology
2013English

The Epidemiology of Left Ventricular Hypertrophy in Type 2 Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2005English

A Study of Prevalence of Left Ventricular Hypertrophy in Type-2 Diabetes Mellitus Patients

Journal of Evidence Based Medicine and Healthcare
2017English

Left Ventricular Diastolic Dysfunction in Nonhuman Primate Model of Dysmetabolism and Diabetes

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2015English

Subclinical Left Ventricular Dysfunction in Asymptomatic Type 1 Diabetic Children

Journal of Cardiology & Current Research
2016English

Chronic Administration of the Nitroxyl Donor 1-Nitrosocyclo Hexyl Acetate Limits Left Ventricular Diastolic Dysfunction in a Mouse Model of Diabetes Mellitus in Vivo

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2015English

Influence of Hypertension, Left Ventricular Hypertrophy, and Left Ventricular Systolic Dysfunction on Plasma N Terminal proBNP

Heart
2000English

Association Between Diabetes Mellitus and Left Ventricular Hypertrophy in a Multiethnic Population

American Journal of Cardiology
Cardiovascular MedicineCardiology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy